Jonathan PoyerJun 23, 20222 minBiotech & HealthcareThe Capital Well is Running Dry For Biotech...For Now
Jonathan PoyerJun 23, 20221 minBiotech & HealthcareMerck & Seagen Merger: Will Antitrust Officials Flex? Or Is There Just Not Enough Juice?
Jonathan PoyerJun 16, 20221 minVolatility Investing and the VIXWhat To Do With a Problem Like 60/40 Investing